ESSA Pharma Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three in USD from Q4 2023 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
ESSA Pharma Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and growth rate from Q4 2023 to Q1 2025.
  • ESSA Pharma Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending March 31, 2025 was $46.2K, a 66% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Growth (%)

ESSA Pharma Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $46.2K -$89.7K -66% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $80.3K -$54.5K -40.4% Dec 31, 2024 10-Q 2025-02-11
Q3 2024 $114K Sep 30, 2024 10-K 2024-12-17
Q2 2024 $137K Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $136K Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $135K Dec 31, 2023 10-Q 2024-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.